Bipolar disorder trials in India

In India 6 Also abroad 235

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
Where
Belagavi, Hyderabad, Kolkata, Kozhikode, Ludhiana, Madurai, Vadodara, Visakhapatnam
Age
18 years to 65 years
People
274 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06951711
Phase 2Taking people
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Where
Belgavi, Bhopal, Chhatrapati Sambhajinagar, Dehradun, Dharwad, Lucknow, Mysore, Nashik, Pune, Tiruchirappalli, Varanasi
Age
18 years to 75 years
People
400 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07286175
Phase 3Taking people
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Where
Ahmedabad, Chhatrapati Sambhajinagar, Nashik, Varanasi
Age
10 years to 17 years
People
384 worldwide
Run by
Intra-Cellular Therapies, Inc.
See details and how to joinNCT06372964
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Where
Kolkata, Madurai, Mangalore, Mangaluru
Age
18 years to 65 years
People
424 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07140913
Phase 3Taking people
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Where
Belagavi, Hyderabad, Kolkata, Kozhikode, Ludhiana, Madurai, Mangalore, Vadodara
Age
18 years to 65 years
People
450 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06929273 · EU 2024-520259-26-00
Phase 1/2Taking people
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
Where
Ahmedabad
Age
18 years to 64 years
People
24 worldwide
Run by
Mapi Pharma Ltd.
See details and how to joinNCT07185815